ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 55236 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 55236; 2) Community: the network communities that were significantly associated with the response to NSC 55236; 3) Molecule: the relationships between components within communities and NSC 55236; 4) MDR: the compounds that were significantly associated with the NSC 55236.

NSC Compound Enrichment Correlation
NSC 718564 Null 0.022188614181866 0.26854163
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.022188614181866 0.34352853
NSC 726217 Combretastatin A4-analogue 0.022188614181866 0.14807114
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.022188614181866 0.027468478
NSC 743532 Null 0.022188614181866 0.12960063
NSC 744688 Null 0.022188614181866 0.10180163
NSC 753427 2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.022188614181866 0.057925946
NSC 755442 Null 0.022188614181866 0.12352502
NSC 602066 1-Penten-3-one, 1,1'-(1,4-phenylene)bis[5-(diethylamino)- 4,4-dimethyl-, dihydrobromide 0.0235234559682125 0.34079866
NSC 628572 Null 0.0235234559682125 0.2903469
Total:59  Current:27    [First] [Prev] [Next] [Last]